Does a sirolimus-eluting stent prevent neointimal proliferation, restenosis, and associated clinical events compared to a standard coronary stent in patients requiring coronary revascularization?
A sirolimus-eluting stent shows promise in preventing restenosis and clinical events compared to standard stents for coronary revascularization.
As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events.
Morice et al. (Thu,) studied this question.